Tvardi Therapeutics, Inc. - Common stock, par value $0.001 per share (TVRD)

Historical Holders from Q2 2025 to Q3 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Symbol
TVRD on Nasdaq
Shares outstanding
9,388,240
Price per share
$4.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,603,802
Total reported value
$101,367,311
% of total 13F portfolios
0%
Share change
+679,986
Value change
+$26,943,938
Number of holders
63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tvardi Therapeutics, Inc. - Common stock, par value $0.001 per share (TVRD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Slate Path Capital LP 7.5% $21,320,693 704,118 Slate Path Capital LP 30 Jun 2025
Vifor (International) Ltd 2.2% 205,465 Vifor (International) Ltd. 15 Apr 2025
As of 30 Sep 2025, Tvardi Therapeutics, Inc. - Common stock, par value $0.001 per share (TVRD) has 63 institutional shareholders filing 13F forms. They hold 2,603,802 shares. of 9,388,240 outstanding shares (28%) .

Top 25 institutional shareholders own 27% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Slate Path Capital LP 7.5% 704,118 0% 0.42% $27,439,478
VANGUARD GROUP INC 4.5% 419,167 +5.2% 0% $16,334,938
BlackRock, Inc. 3.5% 329,914 +23% 0% $12,856,749
683 Capital Management, LLC 1.9% 176,030 0% 0.61% $6,768,424
Vestal Point Capital, LP 1.8% 167,000 0.3% $6,507,990
GEODE CAPITAL MANAGEMENT, LLC 1.6% 147,919 +32% 0% $5,765,883
Invesco Ltd. 0.88% 82,614 0% $3,219,468
FMR LLC 0.88% 82,221 +1644320% 0% $3,204,152
Parkman Healthcare Partners LLC 0.69% 65,000 0.28% $2,533,050
STATE STREET CORP 0.67% 62,864 +51% 0% $2,449,810
UBS Group AG 0.52% 48,479 +65% 0% $1,889,227
FARALLON CAPITAL MANAGEMENT LLC 0.46% 43,225 0% 0.01% $1,684,478
NORTHERN TRUST CORP 0.45% 42,383 +39% 0% $1,651,666
RENAISSANCE TECHNOLOGIES LLC 0.32% 30,175 -3.4% 0% $1,175,920
GOLDMAN SACHS GROUP INC 0.26% 24,029 0% $936,410
SILVERCREST ASSET MANAGEMENT GROUP LLC 0.24% 22,366 0.01% $871,603
BOOTHBAY FUND MANAGEMENT, LLC 0.22% 20,189 0.02% $786,765
Schonfeld Strategic Advisors LLC 0.2% 19,132 0.01% $745,573
BANK OF AMERICA CORP /DE/ 0.16% 15,362 -10% 0% $598,657
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.16% 15,274 +27% 0% $595,228
Monaco Asset Management SAM 0.14% 13,590 0.2% $529,602
Bank of New York Mellon Corp 0.1% 9,666 0% $376,684
Squarepoint Ops LLC 0.09% 8,164 0% $318,151
BARCLAYS PLC 0.07% 6,669 +15% 0% $259,891
Nuveen, LLC 0.06% 5,951 0% $231,910

Institutional Holders of Tvardi Therapeutics, Inc. - Common stock, par value $0.001 per share (TVRD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,603,802 $101,367,311 +$26,943,938 $38.97 63
2025 Q2 1,922,982 $44,387,703 +$44,380,704 $23.33 48